WHO Calls for Evidence-Led Future for African Traditional Medicine

The World Health Organization used African Traditional Medicine Day 2026 to press a practical question: how can long-established community knowledge contribute to wider health coverage without lowering the standards of evidence, safety or accountability expected in modern care?

In an update published on August 31, WHO said research, regulation, collaboration and community trust should shape the next phase of traditional medicine in Africa. The organization’s Global Traditional Medicine Centre and Regional Office for Africa convened a discussion under a theme focused on moving traditional medicine “from research to reach” in support of universal health coverage.

That framing matters. WHO is not presenting every traditional practice as proven treatment, and it is not proposing that traditional care replace biomedicine. Its wider strategy calls for careful evaluation, appropriate regulation and integration only where services and products are safe, effective and supported by evidence.

A health resource rooted in communities

African Traditional Medicine Day traces back to a resolution adopted by the WHO Regional Committee for Africa in 2000. WHO says traditional health practitioners remain a first point of contact for many people, especially in rural communities where formal services may be distant, costly or difficult to reach.

The August 31 discussion brought together Martins Emeje, director-general of the Nigeria Natural Medicine Development Agency and co-chair of a WHO advisory group, and Temitayo Faruq Erogbogbo, a traditional leader from Nigeria. Kenyan researcher and entrepreneur Fionah Njeri moderated the conversation.

Participants emphasized that traditional practitioners often hold relationships, language and cultural legitimacy that conventional services may lack. That trust can help people seek care and discuss health concerns earlier. But trust alone cannot establish that a remedy works, determine a safe dose or identify interactions with other treatments. Those questions require documentation, transparent testing and reliable oversight.

Evidence and regulation are central, not optional

WHO’s Global Traditional Medicine Strategy 2025–2034 sets four broad objectives: strengthen the evidence base, support safety and effectiveness through regulation, integrate appropriate services into health systems, and make responsible use of the field’s wider social and economic value.

The strategy also states that it does not prefer traditional practice over biomedical practice. It calls for rigorous research, ethical standards and protection against unsupported claims. That distinction is especially important online, where the label “natural” is sometimes used to imply that a product is automatically safe or effective.

Useful evidence can take several forms. Laboratory work may identify active compounds or toxic effects. Clinical studies can test whether an intervention helps patients and at what dose. Health-system research can examine whether cooperation with community practitioners improves referrals, vaccination, maternal care or management of chronic disease. Regulators also need consistent information about manufacturing quality, contamination and labeling.

This approach leaves room to investigate promising knowledge while protecting patients from exaggeration. It also makes it possible to distinguish practices with measurable benefits from those that are ineffective, unsafe or simply untested.

Preserving knowledge without exploiting it

The WHO discussion also highlighted documentation. Oral traditions can disappear when knowledgeable elders die or when younger generations leave their communities. Recording that knowledge may support research and cultural preservation, but it also raises questions about consent, ownership and benefit-sharing.

WHO’s strategy recognizes Indigenous rights, biodiversity and sustainability as guiding principles. Researchers and companies therefore need more than access to a plant or a description of its use. Communities should understand how knowledge will be studied, how results may be commercialized and whether benefits will return to the people who preserved it.

Environmental limits matter as well. Greater demand for a medicinal plant can damage wild populations if harvesting grows faster than cultivation or conservation. A responsible research pathway must consider health outcomes, local livelihoods and ecological effects together.

What implementation could look like

WHO said commemorations were planned in several countries, including Cameroon, Madagascar, Mozambique, South Africa and Zimbabwe. The events create visibility, but the longer-term test will be whether governments turn discussion into workable rules and services.

That could include national registration systems for practitioners, quality standards for herbal products, reporting channels for adverse effects, referral protocols between traditional and biomedical providers, and research partnerships that include community representatives from the beginning. Training can also help practitioners recognize symptoms that require urgent hospital care.

None of those steps guarantees success, and policies will need to reflect local law, culture and health-system capacity. The strongest common thread in WHO’s message is that inclusion should be evidence-led rather than symbolic.

For patients, the practical advice remains straightforward: tell qualified health professionals about any traditional remedies or supplements being used, particularly during pregnancy or alongside prescription medicines. Cultural respect and scientific scrutiny do not have to compete. Used together, they can help preserve valuable knowledge while keeping safety at the center of care.

Sources: WHO’s African Traditional Medicine Day 2026 update and the WHO Global Traditional Medicine Strategy 2025–2034.